Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 May;159(5):2111-2112.
doi: 10.1016/j.chest.2021.03.003.

Standard Dose Ivermectin for COVID-19

Dora Buonfrate  1 , Zeno Bisoffi  2
Affiliations
Comment

Standard Dose Ivermectin for COVID-19

Dora Buonfrate et al. Chest. 2021 May.
No abstract available

PubMed Disclaimer

Comment in

  • Response.
    Rajter JJ, Rajter JC, Sherman M. Rajter JJ, et al. Chest. 2021 May;159(5):2112-2113. doi: 10.1016/j.chest.2020.11.017. Chest. 2021. PMID: 33965139 No abstract available.

Comment on

References

    1. Cepelowicz Rajter J., Sherman M., Fatteh N. Use of ivermectin is associated with lower mortality in hospitalized patients with coronavirus disease 2019. Chest. 2021;159(1):85–92. - PMC - PubMed
    1. Mehra M.R., Ruschitzka F., Patel A.N. Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. 2020;395(10240):1820. - PMC - PubMed
    1. Horby P., Lim W.S., Emberson J.R., RECOVERY Collaborative Group Dexamethasone in hospitalized patients with Covid-19: preliminary report. N Engl J Med. 2021;384(8):693–704. - PMC - PubMed
    1. Caly L., Druce J.D., Catton M.G. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020;178:104787. - PMC - PubMed
    1. National Institutes of Health Clinical Center. COVidIVERmectin: Ivermectin for treatment of Covid-19 (COVER). NCT04438850. ClinicalTrials.gov. National Institutes of Health; 2020. Updated January 19, 2021. https://clinicaltrials.gov/ct2/show/NCT04438850.